Other

12 months or more

Humana 12 months or more decreased by 11.2% to $7.76B in Q1 2026 compared to the prior quarter. Year-over-year, this metric declined by 11.7%, from $8.79B to $7.76B. Over 3 years (FY 2022 to FY 2025), 12 months or more shows relatively stable performance with a -0.8% CAGR.

Analysis

StatementBalance Sheet Statement
SectionOther
First reportedQ4 2025
Last reportedQ1 2026
Metric ID: other_debt_securities_available_for_sale_continuous_unre_52a0a6

Historical Data

13 periods
 Q4 '22Q1 '23Q2 '23Q4 '23Q1 '24Q2 '24Q3 '24Q4 '24Q1 '25Q2 '25Q3 '25Q4 '25Q1 '26
Value$8.96B$9.08B$9.98B$11.05B$10.56B$11.21B$9.84B$9.10B$8.79B$8.37B$8.76B$8.74B$7.76B
QoQ Change+1.3%+9.9%+10.7%-4.4%+6.1%-12.2%-7.4%-3.5%-4.8%+4.7%-0.3%-11.2%
YoY Change+23.3%+16.3%+12.3%-17.6%-16.8%-25.4%-10.9%-4.0%-11.7%
Range$7.76B$11.21B
CAGR-4.7%
Avg YoY Growth-3.8%
Median YoY Growth-10.9%
Current Streak2 quarters decline

12 months or more at Other Companies

Frequently Asked Questions

What is Humana's 12 months or more?
Humana (HUM) reported 12 months or more of $7.76B in Q1 2026.
How has Humana's 12 months or more changed year-over-year?
Humana's 12 months or more decreased by 11.7% year-over-year, from $8.79B to $7.76B.
What is the long-term trend for Humana's 12 months or more?
Over 3 years (2022 to 2025), Humana's 12 months or more has grown at a -0.8% compound annual growth rate (CAGR), from $8.96B to $8.74B.